Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.

Karnezis, Tom T

Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy. [electronic resource] - The Laryngoscope Mar 2012 - 495-7 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1531-4995

10.1002/lary.22501 doi


Administration, Intranasal
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Bevacizumab
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Injections
Male
Middle Aged
Nasal Mucosa
Prospective Studies
Severity of Illness Index
Telangiectasia, Hereditary Hemorrhagic--diagnosis
Treatment Outcome
Vascular Endothelial Growth Factor A